Journal of Infertility and Reproductive Biology

Published date: Dec 20 2024

Journal Title: Journal of Infertility and Reproductive Biology

Issue title: Journal of Infertility and Reproductive Biology: Volume 12, Issue 4

Pages: 31 - 44

DOI: 10.18502/jirb.v12i4.17976

Mohammadreza Afsharmohammadreza.af2017@gmail.comStudent Research Committee, Bushehr University of Medical Sciences, Bushehr

Alireza AfsharAlireza.af2017@gmail.comStudent Research Committee, Bushehr University of Medical Sciences, Bushehr

Male infertility affects a significant portion of the global population, contributing to nearly half of all infertility cases. Common underlying causes include disruptions in spermatogenesis, hormonal imbalances, and genetic anomalies. Traditional treatments, such as hormone therapy, surgical interventions, and assisted reproductive technologies, often exhibit limited efficacy due to their invasive nature, systemic side effects, and high financial costs. This study explores nanomedicine’s potential as a targeted approach to address these limitations, particularly through advanced nanoparticle-based drug delivery systems aimed at enhancing sperm function and improving fertility outcomes. Various types of nanoparticles, including liposomes, polymer-based nanoparticles, and metal nanoparticles, are assessed for their abilities to deliver therapeutic agents directly to spermatogenic cells and support cells in the testes. By modulating critical cellular pathways necessary for sperm production and survival, nanoparticles offer enhanced therapeutic effects with minimized systemic exposure. Additionally, the study highlights the potential of nanoparticle applications in personalized reproductive medicine, allowing for tailored treatment approaches based on individual profiles. Although further clinical trials are needed to confirm efficacy and safety, nanoparticle-based therapies offer a promising path forward in the minimally invasive, targeted treatment of male infertility.

Keywords: Male Infertility, Nanoparticles, Drug Delivery Systems, Spermatogenesis, Reproductive Medicine

[1] Agarwal A, Baskaran S, Parekh N, Cho C-L, Henkel R, Vij S, et al. Male infertility. The Lancet. 2021;397(10271):319-33.

[2] Verma O, Kumar R, Kumar A, Chand S. Assisted Reproductive Techniques in Farm Animal-From Artificial Insemination to Nanobiotechnology. Veterinary World. 2012;5(5).

[3] Levine H, Jørgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Mindlis I, et al. Temporal trends in sperm count: a systematic review and meta-regression analysis. Human reproduction update. 2017;23(6):646-59.

[4] Choy JT, Ellsworth P. Overview of current approaches to the evaluation and management of male infertility. Urologic Nursing. 2012;32(6).

[5] Sengupta P, Arafa M, Elbardisi H. Hormonal regulation of spermatogenesis. Molecular signaling in spermatogenesis and male infertility: CRC Press; 2019. p. 41-9.

[6] Tüttelmann F, Werny F, Cooper T, Kliesch S, Simoni M, Nieschlag E. Clinical experience with azoospermia: aetiology and chances for spermatozoa detection upon biopsy. International journal of andrology. 2011;34(4pt1):291-8.

[7] Agarwal A, Sengupta P. Oxidative stress and its association with male infertility. Male infertility: contemporary clinical approaches, andrology, ART and antioxidants. 2020:57-68.

[8] Krausz C, Rosta V, Swerdloff RS, Wang C. Genetics of male infertility. Emery and rimoin’s principles and practice of medical genetics and genomics. 2022:121-47.

[9] Sengupta P, Dutta S, Karkada IR, Chinni SV. Endocrinopathies and male infertility. Life. 2021;12(1):10.

[10] Sengupta P. Environmental and occupational exposure of metals and their role in male reproductive functions. Drug and chemical toxicology. 2013;36(3):353-68.

[11] Sharma R, Biedenharn KR, Fedor JM, Agarwal A. Lifestyle factors and reproductive health: taking control of your fertility. Reproductive biology and endocrinology. 2013;11:1-15.

[12] Jayasena CN, Anderson RA, Llahana S, Barth JH, MacKenzie F, Wilkes S, et al. Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clinical endocrinology. 2022;96(2):200-19.

[13] Esteves SC, Majzoub A, Agarwal A. Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples. Translational Andrology and Urology. 2017:S629-S31.

[14] Schlegel P. Evaluation of male infertility. Minerva ginecologica. 2009;61(4):261-83.

[15] Zhao F, Fan M, Jing Z, Zhang Y, Wang Y, Zhou C, et al. Engineered nanoparticles potentials in male reproduction. Andrology. 2024.

[16] Acharya B, Behera A, Behera S, Moharana S. Recent advances in nanotechnology-based drug delivery systems for the diagnosis and treatment of reproductive disorders. ACS Applied Bio Materials. 2024;7(3):1336-61.

[17] Thangaraj P, Junior LJQ, Ponpandian N. Nanophytomedicine: an emerging platform for drug delivery: CRC Press; 2022.

[18] Sperling RA, Gil PR, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chemical Society Reviews. 2008;37(9):1896-908.

[19] Taylor U, Barchanski A, Kues W, Barcikowski S, Rath D. Impact of metal nanoparticles on germ cell viability and functionality. Reproduction in Domestic Animals. 2012;47:359-68.

[20] Mukherjee AG, Gopalakrishnan AV, Mukherjee A. The application of nanomaterials in designing promising diagnostic, preservation, and therapeutic strategies in combating male infertility: A review. Journal of Drug Delivery Science and Technology. 2024:105356.

[21] Liu Y, Li X, Xiao S, Liu X, Chen X, Xia Q, et al. The effects of gold nanoparticles on Leydig cells and male reproductive function in mice. International Journal of Nanomedicine. 2020:9499-514.

[22] Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicology letters. 2008;176(1):1-12.

[23] Kovacic P, Somanathan R. Nanoparticles: toxicity, radicals, electron transfer, and antioxidants. Oxidative Stress and Nanotechnology: Methods and Protocols. 2013:15-35.

[24] Barkalina N, Jones C, Kashir J, Coote S, Huang X, Morrison R, et al. Effects of mesoporous silica nanoparticles upon the function of mammalian sperm in vitro. Nanomedicine: Nanotechnology, Biology and Medicine. 2014;10(4):859-70.

[25] Slowing II, Trewyn BG, Giri S, Lin VY. Mesoporous silica nanoparticles for drug delivery and biosensing applications. Advanced Functional Materials. 2007;17(8):1225-36.

[26] Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nature materials. 2005;4(6):435-46.

[27] Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-coglycolide)( PLGA) devices. Biomaterials. 2000;21(23):2475-90.

[28] Luo L, Zhou H, Wang S, Pang M, Zhang J, Hu Y, et al. The application of nanoparticle-based imaging and phototherapy for female reproductive organs diseases. Small. 2023:2207694.

[29] Donahue ND, Acar H, Wilhelm S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Advanced drug delivery reviews. 2019;143:68-96.

[30] Ilani M, Alaee S, Khodabandeh Z, Jamhiri I, Owjfard M. Effect of titanium dioxide nanoparticles on the expression of apoptotic markers in mouse blastocysts. Toxicological & Environmental Chemistry. 2018;100:228-234

[31] Bakhtari A, Nazari S, Alaee S, Kargar-Abarghouei E, Mesbah F, Mirzaei E, Molaei MJ.Effects of Dextran- Coated Superparamagnetic Iron Oxide Nanoparticles on Mouse Embryo Development, Antioxidant Enzymes and Apoptosis Genes Expression, and Ultrastructure of Sperm, Oocytes and Granulosa Cells. International Journal of Fertility and Sterility. 2022;14:161.

[32] 30. Aitken RJ, Curry BJ. Redox regulation of human sperm function: from the physiological control of sperm capacitation to the etiology of infertility and DNA damage in the germ line. Antioxidants & redox signaling. 2011;14(3):367-81.

[33] Yao Y, Zhang T, Tang M. The DNA damage potential of quantum dots: Toxicity, mechanism and challenge. Environmental Pollution. 2023;317:120676.

[34] Orlando A, Colombo M, Prosperi D, Gregori M, Panariti A, Rivolta I, et al. Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages. Journal of Nanoparticle Research. 2015;17:1-13.

[35] de PF Dantas G, Ferraz FS, Coimbra JL, Paniago RM, Dantas MS, Lacerda SM, et al. The toxicity of superparamagnetic iron oxide nanoparticles induced on the testicular cells: In vitro study. NanoImpact. 2024;35:100517.

[36] Barkalina N, Charalambous C, Jones C, Coward K. Nanotechnology in reproductive medicine: emerging applications of nanomaterials. Nanomedicine: Nanotechnology, Biology and Medicine. 2014;10(5):e921-e38.

[37] Bell IR, Ives JA, Wayne BJ. Nonlinear effects of nanoparticles: biological variability from hormetic doses, small particle sizes, and dynamic adaptive interactions. Dose-Response. 2014;12(2):dose-response. 13- 025. Bell.

[38] Ryu JH, Lee S, Son S, Kim SH, Leary JF, Choi K, et al. Theranostic nanoparticles for future personalized medicine. Journal of controlled release. 2014;190:477-84.

[39] Fraser B, Peters AE, Sutherland JM, Liang M, Rebourcet D, Nixon B, et al. Biocompatible nanomaterials as an emerging technology in reproductive health; a focus on the male. Frontiers in physiology. 2021;12:753686.

[40] Davidson LM, Barkalina N, Coward K. Development of nanoparticle-mediated delivery tools to investigate the role of molecular genetic mechanisms underlying male infertility. Science Advances Today. 2016;1:25210.